Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 10/2017

01-10-2017 | Review on Health Services Research

Leveraging the electronic health record to improve quality and safety in rheumatology

Authors: Gabriela Schmajuk, Jinoos Yazdany

Published in: Rheumatology International | Issue 10/2017

Login to get access

Abstract

During the last two decades, improving the quality and safety of healthcare has become a focus in rheumatology. Widespread use of electronic health records (EHRs) and the availability of digital data have the potential to drive quality improvement, improve patient outcomes, and prevent adverse events. In the coming years, developing and leveraging tools within the EHR will be the key to making the next big strides in improving the health of patients with rheumatoid arthritis and other rheumatic diseases, including building EHR infrastructure to capture patient outcomes and developing automated methods to retrieve information from free text of clinical notes.
Literature
1.
Dragoi RG, Ndosi M, Sadlonova M et al (2013) Patient education, disease activity and physical function: can we be more targeted? A cross sectional study among people with rheumatoid arthritis, psoriatic arthritis and hand osteoarthritis. Arthrits Res Ther 15(5):R156CrossRef
2.
Kjeken I, Dagfinrud H, Mowinckel P et al (2006) Rheumatology care: involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 55(3):394–401CrossRefPubMed
3.
Nota I, Drossaert CH, Taal E et al (2014) Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey. BMC Musculoskelet Disord 15:333CrossRefPubMedPubMedCentral
4.
Bourgeois FT, Shannon MW, Valim C et al (2010) Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf 19(9):901–910CrossRefPubMedPubMedCentral
5.
6.
Smolen JS, Aletaha D, Bijlsma JWJ et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631–637CrossRefPubMedPubMedCentral
7.
Institute of Medicine (2012) The learning health care system in America. National Academies Press, Washington, DC
8.
Schoels M, Knevel R, Aletaha D et al (2010) Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann Rheum Dis 69:638–643CrossRefPubMedPubMedCentral
9.
Grigor C, Capell H, Stirling A et al (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364:263–269CrossRefPubMed
10.
Verstappen SMM, Jacobs JWG, van der Veen MJ et al (2007) Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 66:1443–1449CrossRefPubMedPubMedCentral
11.
Allaart CF, Geokoop-Ruiterman YPM, de Vries-Bouwstra JK et al (2006) Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study. Clin Exp Rheumatol 24(6 Suppl 43):S-77–S-82
12.
Alemao E, Joo S, Kawabata H et al (2016) Effects of achieving target measures in rheumatoid arthritis on functional status, quality of life, and resource utilization: analysis of clinical practice data. Arthritis Care Res (Hoboken) 68(3):308–317CrossRef
13.
Curtis JR, Shan Y, Harrold L et al (2013) Patient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomes. Arthritis Care Res (Hoboken) 65(10):1707–1712
14.
Lavallee DC, Chenok KE, Love RM et al (2016) Incorporating patient-reported outcomes into health care to engage patients and enhance care. Health Aff (Millwood) 35(4):575–582CrossRef
15.
16.
Yazdany J, Robbins M, Schmajuk G et al (2016) Development of the American College of Rheumatology’s rheumatoid arthritis electronic clinical quality measures. Arthritis Care Res 68(11):1579–1590CrossRef
17.
18.
19.
Navarro-Compan V, Smolen JS et al (2015) Quality indicators in rheumatoid arthritis: results from the METEOR database. Rheumatology (Oxford, England) 54(9):1630–1639CrossRef
20.
Sapir T, Rusie E, Greene L et al (2015) Influence of continuing medical education on rheumatologists’ performance on national quality measures for rheumatoid arthritis. Rheumatol Ther 2(2):141–151CrossRefPubMedPubMedCentral
21.
Yazdany J, Bansback N, Clowse M et al (2016) Rheumatology informatics system for effectiveness: a national informatics-enabled registry for quality improvement. Arthritis Care Res 68(12):1866–1873CrossRef
22.
Walsh SH (2004) The clinician’s perspective on electronic health records and how they can affect patient care. Br Med J 328:1184–1187CrossRef
23.
24.
Powsner SM, Wyatt JC, Wright P (1998) Opportunities for and challenges of computerisation. Lancet 352:1617–1622CrossRefPubMed
25.
Brown T (2008) Design thinking. Harv Bus Rev 862008:84–92
26.
27.
Carroll RJ, Thompson WK, Eyler AE et al (2012) Portability of an algorithm to identify rheumatoid arthritis in electronic health records. J Am Med Inform Assoc JAMIA 19(e1):e162–e169CrossRefPubMed
28.
29.
Liao KP, Cai T, Gainer V et al (2010) Electronic medical records for discovery research in rheumatoid arthritis. Arthritis Care Res (Hoboken) 62(8):1120–1127CrossRef
30.
Lin C, Karlson EW, Dligach D et al (2015) Automatic identification of methotrexate-induced liver toxicity in patients with rheumatoid arthritis from the electronic medical record. J Am Med Inform Assoc 22(e1):e151–e161CrossRefPubMed
31.
Hernandez Boussard T, Tamang S, Blayney D et al (2016) New paradigms for patient-centered outcomes research in electronic medical records: an example of detecting urinary incontinence following prostatectomy. EGEMS (Wash DC) 4(3):1231
32.
Tamang S, Patel MI, Blayney DW et al (2015) Detecting unplanned care from clinician notes in electronic health records. J Oncol Pract 11(3):e313–e319CrossRefPubMedPubMedCentral
33.
34.
Harpaz R, Callahan A, Tamang S et al (2014) Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf 37(10):777–790CrossRefPubMedPubMedCentral
35.
Meystre SM, Savova GK, Kipper-Schuler KC, Hurdle JF (2008) Extracting information from textual documents in the electronic health record: a review of recent research. In: Yearbook of medical informatics, vol 35, pp 128–144
36.
Friedman C, Rindflesch TC, Corn M (2013) Natural language processing: state of the art and prospects for significant progress, a workshop sponsored by the National Library of Medicine. J Biomed Inform 46(5):765–773CrossRefPubMed
37.
Ford E, Carroll JA, Smith HE et al (2016) Extracting information from the text of electronic medical records to improve case detection: a systematic review. J Am Med Inform Assoc 23(5):1007–1015CrossRefPubMedPubMedCentral
38.
Perrillo RP, Martin P, Lok AS (2015) Preventing hepatitis B reactivation due to immunosuppressive drug treatments. JAMA 313(16):1617–1618CrossRefPubMed
39.
Yazdany J, Calabrese L (2010) Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines? Arthritis Care Res (Hoboken) 62(5):585–589CrossRef
40.
Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345(15):1098–1104CrossRefPubMed
41.
Carmona L, Hernandez-Garcia C, Vadillo C et al (2003) Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 30(7):1436–1439PubMed
42.
Clowse ME, Magder L, Petri M (2005) Cyclophosphamide for lupus during pregnancy. Lupus 14(8):593–597CrossRefPubMed
43.
Jackson P, Paquette L, Watiker V et al (2009) Intrauterine exposure to mycophenolate mofetil and multiple congenital anomalies in a newborn: possible teratogenic effect. Am J Med Genet Part A 149A(6):1231–1236CrossRefPubMed
44.
Yazdany J, Trupin L, Kaiser R et al (2011) Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality? Arthritis Care Res (Hoboken) 63(3):358–365
45.
Schwarz EB, Longo LS, Zhao X et al (2010) Provision of potentially teratogenic medications to female veterans of childbearing age. Med Care 48(9):834–842CrossRefPubMed
46.
Hwang JP, Somerfield MR, Alston-Johnson DE et al (2015) Hepatitis B virus screening for patients with cancer before therapy: american society of clinical oncology provisional clinical opinion update. J Clin Oncol 33(19):2212–2220CrossRefPubMedPubMedCentral
47.
Weinbaum CM, Mast EE, Ward JW (2009) Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology 49(5 Suppl):S35–S44CrossRefPubMed
48.
Reddy KR, Beavers KL, Hammond SP et al (2015) American gastroenterological association institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology 148:215–219CrossRefPubMed
49.
Perrillo RP, Gish R, Falck-Ytter YT (2015) American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology 148(1):221–244CrossRefPubMed
50.
Huang YH, Hsiao LT, Hong YC et al (2013) Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B. J Clin Oncol 31:2765–2772CrossRefPubMed
51.
Buti M, Morillas R, Manzano ML et al (2014) Tenofovir for the prophylaxis of HBV reactivation in anti-HBc-positive patients with hematologic malignancies treated with rituximab: preliminary results of a randomized study (PREBLIN Study). J Hepatol 60(1):S421–S422CrossRef
52.
Kohler MJ, Amezaga M, Drozd J et al (2013) Use of a computerized order set to increase prescription of calcium and vitamin D supplementation in patients receiving glucocorticoids. J Gen Intern Med 28(6):825–829CrossRefPubMedPubMedCentral
53.
Chaudhry R, Schietel SM, North F et al (2013) Improving rates of herpes zoster vaccination with a clinical decision support system in a primary care practice. J Eval Clin Pract 19(2):263–266CrossRefPubMed
54.
van der Sijs H, Aarts J, Vulto A, Berg M (2006) Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 13(2):138–147 (Epub 2005 Dec 15) CrossRefPubMedPubMedCentral
55.
Suter LG, Barber CE, Herrin J et al (2016) American College of Rheumatology White Paper on performance outcome measures in rheumatology. Arthritis Care Res (Hoboken) 68(10):1390–1401CrossRef
56.
Mannion R, Braithwaite J (2012) Unintended consequences of performance measurement in healthcare: 20 salutary lessons from the English National Health Service. Intern Med J 42(5):569–574CrossRefPubMed
57.
Ramsey CR, Matowe L, Grilli R et al (2003) Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behaviour change strategies. Int J Technol Assess Health Care 19(4):613–623CrossRef
58.
Harris AD, McGregor JC, Perencevich EN et al (2006) The use and interpretation of quasi-experimental studies in medical informatics. J Am Med Inform Assoc 13(1):16–23 (Epub 2005 Oct 12) CrossRefPubMedPubMedCentral
59.
Lewis RJ (2016) The pragmatic clinical trial in a learning health care system. Clin Trials 13(5):484–492CrossRefPubMed
60.
Mainous AG 3rd, Lambourne CA, Nietert PJ (2013) Impact of a clinical decision support system on antibiotic prescribing for acute respiratory infections in primary care: quasi-experimental trial. J Am Med Inform Assoc 20(2):317–324CrossRefPubMed
61.
Titsworth WL, Abram J, Guin P et al (2016) A prospective time-series quality improvement trial of a standardized analgesia protocol to reduce postoperative pain among neurosurgery patients. J Neurosurg 125(6):1523–1532CrossRefPubMed
62.
Green H, Paul M, Vidal L et al (2007) Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 82(9):1052–1059CrossRefPubMed
63.
Jones RB, Tervaert JW, Hauser T et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363(3):211–220CrossRefPubMed
64.
Singh JA, Furst DE, Bharat A et al (2012) 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64(5):625–639CrossRef
65.
Bhatt DL, Scheiman J, Abraham NS et al (2008) ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol 103(11):2890CrossRefPubMed
66.
Saag KG, Teng GG, Patkar NM et al (2008) American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59(6):762–784CrossRefPubMed
67.
Shea B, Swinden MV, Tanjong Ghogomu E et al (2013) Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 41(6):1049–1060. doi:10.​3899/​jrheum.​130738
68.
Marmor MF, Kellner U, Lai TY, American Academy of Ophthalmology et al (2016) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology 2016(123):1386–1394CrossRef
Metadata
Title
Leveraging the electronic health record to improve quality and safety in rheumatology
Authors
Gabriela Schmajuk
Jinoos Yazdany
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 10/2017
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3804-4

Other articles of this Issue 10/2017

Rheumatology International 10/2017 Go to the issue

Epidemiology of RMD

Juvenile systemic sclerosis: experience from a tertiary care center from India

Epidemiology of RMD

Incidence of inflammatory joint diseases in Finland: results from a population-based epidemiological study

Food for Thought

A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases

Food for Thought

Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression

Biomarkers

Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis

Observational Research

Real-world clinical experience of biological disease modifying anti-rheumatic drugs in Malaysia rheumatoid arthritis patients
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits